Encephalopathy induced by levetiracetam added to valproate

Acta Neurol Scand. 2008 May;117(5):374-6. doi: 10.1111/j.1600-0404.2007.00974.x. Epub 2007 Dec 12.

Abstract

Background: We report on the manifestation of a levetiracetam (LEV)-induced encephalopathy.

Findings: A 28-year-old man suffering from idiopathic epilepsy with generalized seizures was treated with LEV (3000 mg) added to valproate (VPA) (2000 mg). Frequency of generalized tonic-clonic seizures increased from one per 6 months to two per month. Neuropsychological testing showed impaired word fluency, psychomotor speed and working memory. The interictal electroencephalogram (EEG) showed a generalized slowing to 5 per second theta rhythms with bilateral generalized high-amplitude discharges.

Outcome: Following discontinuation of LEV, EEG and neuropsychological findings improved and seizure frequency decreased.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticonvulsants / adverse effects*
  • Brain Diseases / chemically induced*
  • Electroencephalography / methods
  • Epilepsy / drug therapy
  • Humans
  • Levetiracetam
  • Male
  • Piracetam / adverse effects
  • Piracetam / analogs & derivatives*
  • Valproic Acid / adverse effects*

Substances

  • Anticonvulsants
  • Levetiracetam
  • Valproic Acid
  • Piracetam